It also plays a role in stimulating MEK/ERK signaling and the suppression of the RASSF1A tumor suppressor, which impedes the RAF/MEK/ERK pathway and additionally is one of the most frequently inactivated genes in human cancers [74,81,82]. Here, MAP2K7 is linked to cancer.